DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury-Reference-Cited by-同舟云学术

DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury

Published:2016-02-15 Issue:5 Volume:96 Page:547-560
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Eun Lee Jee,Kim Jung Eun,Lee Mi Hwa,Song Hye Kyoung,Ghee Jung Yeon,Kang Young Sun,Min Hye Sook,Kim Hyun Wook,Cha Jin Joo,Han Jee Young,Han Sang Youb,Cha Dae Ryong

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/labinvest201634.pdf

Reference37 articles.

1. Martin JH, Deacon CF, Gorrell MD et al. Incretin-based therapies—review of the physiology, pharmacology and emerging clinical experience. Intern Med J 2011;41:299–307.

2. Campos RV, Lee YC, Drucker DJ . Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 1994;134:2156–2164.

3. Bullock BP, Heller RS, Habener JF . Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 1996;137:2968–2978.

4. Hirata K, Kume S, Araki S et al. Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model. Biochem Biophys Res Commun 2009;380:44–49.

5. Sivertsen J, Rosenmeier J, Holst JJ et al. The effect of glucagon-like peptide 1 on cardiovascular risk. Nat Rev Cardiol 2012;9:209–222.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells;Viruses;2024-08-02

2. Bidirectional relation between dipeptidyl peptidase 4 and angiotensin II type I receptor signaling;American Journal of Physiology-Cell Physiology;2024-04-01

3. Vildagliptin Treatment Ameliorates Renal Interstitial Fibrosis in a Murine Model of Unilateral Ureteral Obstruction;Biological and Pharmaceutical Bulletin;2024-01-01

4. Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho;Renal Failure;2023-02

5. Unraveling the interplay between dipeptidyl peptidase 4 and the renin-angiotensin system in heart failure;Life Sciences;2022-09